Prediction of type 2 diabetes: the dawn of polygenetic testing for complex disease J. B. Meigs Commentary 12 February 2009 Pages: 568 - 570
Adipose tissue–skeletal muscle crosstalk: are endocannabinoids an unwanted caller? M. J. Watt Commentary 10 February 2009 Pages: 571 - 573
Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants M. A. Abdul-GhaniR. JaniR. A. DeFronzo Article 30 January 2009 Pages: 574 - 582
Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT) B. HildrumA. MykletunK. Midthjell Article 05 February 2009 Pages: 583 - 590
Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study J. PoehlsC. L. Wasselfor the Health ABC Study Short Communication Open access 22 January 2009 Pages: 591 - 595
Cardiovascular risk factors in the normoglycaemic Asian-Indian population—influence of urbanisation C. SnehalathaA. Ramachandran Short Communication 10 February 2009 Pages: 596 - 599
Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study X. LinK. SongV. Mooser Article 13 January 2009 Pages: 600 - 608
PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene × environment interactions in children from the European Youth Heart Study E. C. BritoK. S. VimaleswaranP. W. Franks Article 29 January 2009 Pages: 609 - 613
TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study E. S. StolermanA. K. ManningJ. C. Florez Article 31 January 2009 Pages: 614 - 620
A simple two-step protocol for the purification of human pancreatic beta cells M. BanerjeeT. Otonkoski Short Communication 24 January 2009 Pages: 621 - 625
Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis S. ZraikaR. L. HullS. E. Kahn Article 16 January 2009 Pages: 626 - 635
Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets M. ShakedM. Ketzinel-GiladG. Leibowitz Article 13 February 2009 Pages: 636 - 644
Differentiation of COPAS-sorted non-endocrine pancreatic cells into insulin-positive cells in the mouse R. KikugawaH. KatsutaS. Bonner-Weir Article 30 January 2009 Pages: 645 - 652
Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice M. AkiyamaM. HatanakaY. Tanizawa Article 04 February 2009 Pages: 653 - 663
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle K. EckardtH. SellJ. Eckel Article 17 December 2008 Pages: 664 - 674
Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet T. KusakabeH. TaniokaK. Nakao Article 24 January 2009 Pages: 675 - 683
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations A. KotronenV. R. VelagapudiH. Yki-Järvinen Article 13 February 2009 Pages: 684 - 690
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis G. M. MageeR. W. BilousD. G. Fogarty Meta-analysis 07 February 2009 Pages: 691 - 697
Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients S. T. KnudsenE. LaugesenP. L. Poulsen Article 29 January 2009 Pages: 698 - 704
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study J. W. M. NinI. FerreiraEURODIAB Prospective Complications Study Group Article Open access 30 January 2009 Pages: 705 - 714
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study G. J. S. CooperA. A. YoungR. N. Doughty Article 27 January 2009 Pages: 715 - 722
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial D. K. ColettaA. SriwijitkamolR. A. DeFronzo Article 24 January 2009 Pages: 723 - 732
A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population C. HuR. ZhangW. Jia Erratum 12 February 2009 Pages: 733 - 733